Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Astrocytoma AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Treatment
679 results:

  • 1. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. WTAP regulates the production of reactive oxygen species, promotes malignant progression, and is closely related to the tumor microenvironment in glioblastoma.
    Ji Q; Guo Y; Li Z; Zhang X
    Aging (Albany NY); 2024 Mar; 16(6):5601-5617. PubMed ID: 38535989
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.
    Jhanwar-Uniyal M; Zeller SL; Spirollari E; Das M; Hanft SJ; Gandhi CD
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474373
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study.
    Lu F; Wu Q; Lei J; Zhou Y; Liu Y; Zhu N; Yu Y; Lin L; Hu M
    Arch Biochem Biophys; 2024 Apr; 754():109957. PubMed ID: 38467357
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CD133 significance in glioblastoma development: in silico and in vitro study.
    Abdoli Shadbad M; Nejadi Orang F; Baradaran B
    Eur J Med Res; 2024 Mar; 29(1):154. PubMed ID: 38448914
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Betulinic Acid for Glioblastoma treatment: Reality, Challenges and Perspectives.
    Fernandes S; Vieira M; Prudêncio C; Ferraz R
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396785
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Antiproliferative effect of Potentilla fulgens on glioblastoma cancer cells through downregulation of akt/mTOR signaling pathway.
    Kandemir SI; Ipek P
    J Cancer Res Ther; 2023 Oct; 19(7):1818-1824. PubMed ID: 38376284
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exploring the therapeutic mechanisms and prognostic targets of Biochanin A in glioblastoma via integrated computational analysis and in vitro experiments.
    Ge W; Yuan G; Wang D; Dong L
    Sci Rep; 2024 Feb; 14(1):3783. PubMed ID: 38360888
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/akt/mTOR signaling pathway.
    Dong J; Qian Y; Zhang W; Xu J; Wang L; Fan Z; Jia M; Wei L; Yang H; Luo X; Wang Y; Jiang Y; Huang Z; Wang Y
    Eur J Pharmacol; 2024 Apr; 968():176401. PubMed ID: 38331340
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
    Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
    J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma.
    Guo T; Wu C; Zhang J; Yu J; Li G; Jiang H; Zhang X; Yu R; Liu X
    Cell Commun Signal; 2023 Dec; 21(1):363. PubMed ID: 38115126
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Role of Bcl-2 and Beclin-1 Complex in "Switching" between Apoptosis and Autophagy in Human Glioma Cells upon LY294002 and Sorafenib treatment.
    Zając A; Maciejczyk A; Sumorek-Wiadro J; Filipek K; Deryło K; Langner E; Pawelec J; Wasiak M; Ścibiorski M; Rzeski W; Tchórzewski M; Reichert M; Jakubowicz-Gil J
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067099
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. YTHDF3 Modulates EGFR/ATK/ERK/p21 Signaling Axis to Promote Cancer Progression and Osimertinib Resistance of Glioblastoma Cells.
    Lee HH; Hsieh CC; Chang CC; Liao WT; Chi HC
    Anticancer Res; 2023 Dec; 43(12):5485-5498. PubMed ID: 38030188
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Establishment and Comprehensive Molecular Characterization of an Immortalized Glioblastoma Cell Line from a Brazilian Patient.
    da Silva FF; Lupinacci FCS; Elias BDS; Beserra AO; Sanematsu P; Roffe M; Kulikowski LD; Costa FD; Santos TG; Hajj GNM
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958846
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Enhanced Sensitivity to ALDH1A3-Dependent Ferroptosis in TMZ-Resistant Glioblastoma Cells.
    Wu Y; Franzmeier S; Liesche-Starnecker F; Schlegel J
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947601
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
    Krassnig S; Leber SL; Orthmann A; Golob-Schwarzl N; Huber HJ; Wohlrab C; Skofler C; Pennauer M; Raicht A; Birkl-Toeglhofer AM; Naumann M; Mahdy-Ali K; von Campe G; Leoni M; Alcaniz J; Hoffmann J; Wälchli T; Weis S; Benesch M; Haybaeck J
    J Neurooncol; 2023 Oct; 165(1):91-100. PubMed ID: 37907716
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma treatment.
    Singh S; Barik D; Lawrie K; Mohapatra I; Prasad S; Naqvi AR; Singh A; Singh G
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834408
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Glioblastoma CircularRNAome.
    Tirpe A; Streianu C; Tirpe SM; Kocijancic A; Pirlog R; Pirlog B; Busuioc C; Pop OL; Berindan-Neagoe I
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833993
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus.
    Garcia G; Chakravarty N; Paiola S; Urena E; Gyani P; Tse C; French SW; Danielpour M; Breunig JJ; Nathanson DA; Arumugaswami V
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830597
    [TBL] [Abstract] [Full Text] [Related]  


    of 34.